Annual ROE
-12.49%
+12.16%+49.33%
December 1, 2024
Summary
- As of February 26, 2025, VKTX annual return on equity is -12.49%, with the most recent change of +12.16% (+49.33%) on December 1, 2024.
- During the last 3 years, VKTX annual ROE has risen by +14.75% (+54.15%).
- VKTX annual ROE is now -112.63% below its all-time high of 98.90%, reached on December 31, 2014.
Performance
VKTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-12.06%
+0.67%+5.26%
December 1, 2024
Summary
- As of February 26, 2025, VKTX quarterly return on equity is -12.06%, with the most recent change of +0.67% (+5.26%) on December 1, 2024.
- Over the past year, VKTX quarterly ROE has stayed the same.
- VKTX quarterly ROE is now -103.44% below its all-time high of 350.69%, reached on September 30, 2015.
Performance
VKTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VKTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.3% | 0.0% |
| 3 y3 years | +54.1% | +51.9% |
| 5 y5 years | -34.3% | -33.7% |
VKTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.6% | at high | +75.2% |
| 5 y | 5-year | -34.3% | +73.6% | -33.7% | +75.2% |
| alltime | all time | -112.6% | +95.3% | -103.4% | +98.5% |
Viking Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -12.49%(-49.3%) | -12.06%(-5.3%) |
| Sep 2024 | - | -12.73%(-15.4%) |
| Jun 2024 | - | -15.05%(-18.3%) |
| Mar 2024 | - | -18.41%(-33.7%) |
| Dec 2023 | -24.65%(-48.0%) | -27.78%(-11.2%) |
| Sep 2023 | - | -31.28%(-13.8%) |
| Jun 2023 | - | -36.28%(-25.2%) |
| Mar 2023 | - | -48.53%(+13.5%) |
| Dec 2022 | -47.39%(+74.0%) | -42.77%(+21.5%) |
| Sep 2022 | - | -35.20%(+13.5%) |
| Jun 2022 | - | -31.02%(+11.7%) |
| Mar 2022 | - | -27.77%(+10.7%) |
| Dec 2021 | -27.24%(+68.6%) | -25.08%(+7.6%) |
| Sep 2021 | - | -23.31%(+12.8%) |
| Jun 2021 | - | -20.67%(+17.6%) |
| Mar 2021 | - | -17.57%(+14.4%) |
| Dec 2020 | -16.16%(+73.8%) | -15.36%(+13.2%) |
| Sep 2020 | - | -13.57%(+14.0%) |
| Jun 2020 | - | -11.90%(+8.9%) |
| Mar 2020 | - | -10.93%(+21.2%) |
| Dec 2019 | -9.30% | -9.02%(+11.4%) |
| Sep 2019 | - | -8.10%(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -8.26%(-8.8%) |
| Mar 2019 | - | -9.06%(-16.6%) |
| Dec 2018 | -7.41%(-95.2%) | -10.86%(-31.4%) |
| Sep 2018 | - | -15.82%(-55.7%) |
| Jun 2018 | - | -35.69%(-55.2%) |
| Mar 2018 | - | -79.68%(-71.1%) |
| Dec 2017 | -152.84%(-16.6%) | -275.99%(-16.4%) |
| Sep 2017 | - | -330.09%(+49.8%) |
| Jun 2017 | - | -220.35%(+29.9%) |
| Mar 2017 | - | -169.63%(+6.0%) |
| Dec 2016 | -183.17%(-31.7%) | -160.05%(-7.3%) |
| Sep 2016 | - | -172.57%(+2.3%) |
| Jun 2016 | - | -168.75%(-10.5%) |
| Mar 2016 | - | -188.49%(-76.7%) |
| Dec 2015 | -268.24%(-371.2%) | -810.52%(-331.1%) |
| Sep 2015 | - | 350.69%(+205.9%) |
| Jun 2015 | - | 114.65%(+2.3%) |
| Mar 2015 | - | 112.12%(-21.7%) |
| Dec 2014 | 98.90%(+69.5%) | 143.14%(-27.0%) |
| Sep 2014 | - | 196.10%(+1.1%) |
| Jun 2014 | - | 193.89%(+269.2%) |
| Mar 2014 | - | 52.51% |
| Dec 2013 | 58.34% | - |
FAQ
- What is Viking Therapeutics annual return on equity?
- What is the all time high annual ROE for Viking Therapeutics?
- What is Viking Therapeutics annual ROE year-on-year change?
- What is Viking Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Viking Therapeutics?
- What is Viking Therapeutics quarterly ROE year-on-year change?
What is Viking Therapeutics annual return on equity?
The current annual ROE of VKTX is -12.49%
What is the all time high annual ROE for Viking Therapeutics?
Viking Therapeutics all-time high annual return on equity is 98.90%
What is Viking Therapeutics annual ROE year-on-year change?
Over the past year, VKTX annual return on equity has changed by +12.16% (+49.33%)
What is Viking Therapeutics quarterly return on equity?
The current quarterly ROE of VKTX is -12.06%
What is the all time high quarterly ROE for Viking Therapeutics?
Viking Therapeutics all-time high quarterly return on equity is 350.69%
What is Viking Therapeutics quarterly ROE year-on-year change?
Over the past year, VKTX quarterly return on equity has changed by 0.00% (0.00%)